Guideline implementation for breast healthcare in low-income and middle-income countries: Overview of the breast health global initiative Global Summit 2007

Cancer

Volumn 113, Issue 8 SUPPL., 2008, Pages 2221-2243

  Anderson, Benjamin O ^a,b   Yip, Cheng Har ^c   Smith, Robert A ^d   Shyyan, Roman ^e   Sener, Stephen F ^f,g   Eniu, Alexandru ^h   Carlson, Robert W ⁱ   Azavedo, Edward ^j   Harford, Joe ^k  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^d AMERICAN CANCER SOCIETY   (United States)

^e Lviv Cancer Center   (Ukraine)

^f EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

ⁱ STANFORD UNIVERSITY   (United States)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

Breast cancer; Diagnosis; Early detection; Guideline; Healthcare systems; Implementation; Low income countries; Process metrics; Resource allocation; Screening; Treatment

Indexed keywords

ALKYLATING AGENT; ANALGESIC AGENT; ANTHRACYCLINE; AROMATASE INHIBITOR; BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; CISPLATIN; COBALT 60; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; FULVESTRANT; GONADORELIN AGONIST; GROWTH FACTOR; LAPATINIB; METHOTREXATE; MORPHINE; OPIATE; PLATINUM; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

ADVANCED CANCER; BEHAVIOR MODIFICATION; BREAST CANCER; BREAST EXAMINATION; CANCER CENTER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PAIN; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; CURRICULUM DEVELOPMENT; DRUG COST; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; ECHOMAMMOGRAPHY; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; MASTECTOMY; METASTASIS; MONOTHERAPY; MORBIDITY; MULTIMODALITY CANCER THERAPY; ONCOGENE NEU; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT CANCER; RESOURCE ALLOCATION; SOCIAL STATUS; SYSTEMIC THERAPY; UNSPECIFIED SIDE EFFECT; VOCATIONAL EDUCATION;

EID: 56449100677     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23844     Document Type: Conference Paper

References (87)

1. Anderson GF, Chu E. Expanding priorities-confronting chronic disease in countries with low income. N Engl J Med. 2007;356:209-211.
2. World Health Organization. 58th World Health Assembly Approved Resolution on Cancer Prevention and Control WHA58.22. Geneva, Switzerland: World Health Organization; 2005.
3. Sloan FA, Gelband H, eds. Cancer Control Opportunities in Low- and Middle-Income Countries [summary]. Washington, DC: National Academies Press; 2007:1-16.
4. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. version 2.0. Lyon, France: IARC Press; 2004. Available at:http://www-dep.iarc.fr/. Accessed on August 26, 2008.
5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
6. Parkin DM, Fernandez LM. Use of statistics to assess the global burden of breast cancer. Breast J. 2006;12(1 suppl):S70-S80.
7. Stewart B, Kleihues PE. World Cancer Report. Lyon, France: IARC Press; 2003.
8. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. IARC Handbooks of Cancer Prevention. Vol. 7: Breast Cancer Screening. Lyon, France: Oxford University Press; 2002.
9. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med. 2008;358:213-216.
10. Pal SK, Mittal B. Improving cancer care in India: prospects and challenges. Asian Pac J Cancer Prev. 2004;5:226-228.
11. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229-239.
12. Hisham AN, Yip CH. Spectrum of breast cancer in Malaysian women: overview. World J Surg. 2003;27:921-923.
13. Chopra R. The Indian scene. J Clin Oncol. 2001;19(18 suppl):106S-111S.
14. Sant M, Allemani C, Berrino F, et al. Breast carcinoma survival in Europe and the United States. Cancer. 2004;100:715-722.
15. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
16. Zotov V, Shyyan R. Introduction of breast cancer screening in Chernihiv Oblast in the Ukraine: report of a PATH Breast Cancer Assistance Program experience. Breast J. 2003;9 (2 suppl):S75-S80.
17. Carlson RW, Anderson BO, Burstein HJ, et al. Breast cancer. J Natl Compr Canc Netw. 2005;3:238-289.
18. Morrow M, Strom EA, Bassett LW, et al. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin. 2002;52:277-300.
19. Smith RA. Breast cancer screening among women younger than age 50: a current assessment of the issues. CA Cancer J Clin. 2000;50:312-336.
20. Abrams JS. Adjuvant therapy for breast cancer-results from the USA consensus conference. Breast Cancer. 2001;8:298-304.
21. World Health Organization. Executive Summary of the National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva, Switzerland: World Health Organization; 2002.
22. Anderson BO, Braun S, Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003;9(2 suppl):S42-S50.
23. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006;12(1 suppl): S3-S15.
24. Winn RJ, Botnick WZ. The NCCN Guideline Program: a conceptual framework. Oncology (Williston Park). 1997;11:25-32.
25. Anderson BO, Braun S, Lim S, Smith RA, Taplin S, Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J. 2003;9(2 suppl):S51-S59.
26. Smith RA, Caleffi M, Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006;12(1 suppl):S16-S26.
27. Vargas HI, Anderson BO, Chopra R, et al. Diagnosis of breast cancer in countries with limited resources. Breast J. 2003;9(2 suppl):S60-S66.
28. Shyyan R, Masood S, Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006;12(1 suppl):S27-S37.
29. Carlson RW, Anderson BO, Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003;9(2 suppl):S67-S74.
30. Eniu A, Carlson RW, Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006;12(1 suppl):S38-S53.
31. Anderson BO, Yip CH, Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006;12(1 suppl):S54-S69.
32. Yip CH, Smith RA, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008;113(8 suppl):2244-2256.
33. Shyyan R, Sener SF, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middleincome countries: diagnosis resource allocation. Cancer. 2008;113(8 suppl):2257-2268.
34. Eniu A, Carlson RW, El Saghir NS, et al. Guideline implementation for breast healthcare in low- and middleincome countries: treatment resource allocation. Cancer. 2008;113(8 suppl):2269-2281.
35. Harford J, Azavedo E, Fischietto M. Guideline implementation for breast healthcare in low- and middle income countries: breast healthcare program resource allocation. Cancer. 2008;113(8 suppl):2282-2296.
36. Bese NS, Munshi A, Budrukkar A, et al. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer. 2008;113(8 suppl):2305-2314.
37. El Saghir NS, Eniu A, Carlson RW, et al. Locally advanced breast cancer: treatment guidelines and resource-driven implementation. Cancer. 2008;113(8 suppl):2315-2324.
38. Masood S, Vass L, Ibarra JA, et al. Breast pathology guidelines implementation for countries of limited resources. Cancer. 2008;113(8 suppl):2297-2304.
39. McTiernan A, Porter P, Potter JD. Breast cancer prevention in countries with diverse resources. Cancer. 2008;113(8 suppl):2325-2330.
40. Kreps GL, Sivaram R. The central role of strategic health communication in enhancing breast cancer outcomes across the continuum of care in limited-resource countries. Cancer. 2008;113(8 suppl):2331-2337.
41. Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J. 2003;9(2 suppl):S86-S89.
42. Cazap E, Buzaid A, Garbino C, et al. Breast cancer in Latin America: results of the SLACOM/BCRF Expert Survey. Cancer. 2008;113(8 suppl):2359-2365.
43. Pisani P, Parkin DM, Ngelangel C, et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer. 2006;118:149-154.
44. Duffy SW, Tabar L, Vitak B, Warwick J. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography? Breast J. 2006;12(1 suppl):S91-S95.
45. Nadkarni MS, Gupta PB, Parmar VV, Badwe RA. Breast conservation surgery without pre-operative mammography - a definite feasibility. Breast. 2006;15:595-600.
46. Abati A, Simsir A. Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices. Clin Lab Med. 2005;25:631-654.
47. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer [see comments]. Ann Surg. 1994;220:391-398; discussion 398-401.
48. Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA. Revision surgery for breast cancer: single institution experience. Cancer. 2008;113(8 suppl):2247-2252.
49. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiation therapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 B and C randomized studies. J Clin Oncol. 2006;24:2268-2275.
50. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116-126.
51. Bese NS, Kiel K, El-Gueddari Bel K, Campbell OB, Awuah B, Vikram B. Radiotherapy for breast cancer in countries with limited resources: program implementation and evidence-based recommendations. Breast J. 2006;12(1 suppl):S96-S102.
52. Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005;6:391-401.
53. El Saghir NS, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007;5:225-233.
54. Goetz MP, Rae JM, Suman VJ, et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J Clin Oncol. 2005;23:9312-9318.
55. DeMichele A, Aplenc R, Botbyl J, et al. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. J Clin Oncol. 2005;23:5552-5559.
56. Love RR. Defining a global research agenda for breast cancer. Cancer. 2008;113(8 suppl):2366-2371.
57. Buchholz TA, Lehman CD, Harris JR, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol. 2008;26:791-797.
58. Cataliotti L, De Wolf C, Holland R, et al. Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer. 2007;43:660-675.
59. Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol. 2006;7:584-595.
60. Van Der Giessen PH, Alert J, Badri C, et al. Multinational assessment of some operational costs of teletherapy. Radiother Oncol. 2004;71:347-355.
61. Bese NS, Sut PA, Ober A. The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology. 2005;69:214-223.
62. World Health Organization. Essential Medicines. WHO Model List, 2005. Available at: http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf. Accessed on August 26, 2008.
63. Bines J, Eniu A. Effective but cost prohibitive drugs in breast cancer treatment: a clinical review. Cancer. 2008;113(8 suppl):2353-2358.
64. Ratain MJ, Cohen EE. The value meal: how to save $1700 per month or more on lapatinib. J Clin Oncol. 2007;25:3397-3398.
65. Pegram M, Hsu S, Lewis G, et al. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene. 1999;18:2241-2251.
66. World Health Organization. Access to Controlled Medications Programme: Briefing Note, 2007. Available at: http://www.who.int/medicines/areas/ quality_safety/access_to_controlled_medications_brnote_english.pdf. Accessed January 22, 2008.
67. Webster R, Lacey J, Quine S. Palliative care: a public health priority in developing countries. J Public Health Policy. 2007;28:28-39.
68. Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med. 2007;357:608-613.
69. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95:1276-1299.
70. Clarke M. Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol. 2006;17(10 suppl):x59-x62.
71. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
72. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
73. McCannon CJ, Berwick DM, Massoud MR. The science of large-scale change in global health. JAMA. 2007;298:1937-1939.
74. Committee on Quality of Health Cre in America, Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Bethesda, MD: Institute of Medicine; 2001.
75. [No authors listed] IOM committee calls for complete revamping of health care system to achieve better quality. Qual Lett Healthc Lead. 2001;13:14-15.
76. Rubenstein LV, Pugh J. Strategies for promoting organizational and practice change by advancing implementation research. J Gen Intern Med. 2006;21(2 suppl):S58-S64.
77. Grimshaw J, Eccles M, Thomas R, et al. Toward evidence-based quality improvement. Evidence (and its limitations) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med. 2006;21(2 suppl):S14-S20.
78. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82:581-629.
79. Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A. Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer. 2008;113(8 suppl):2338-2346.
80. The NCCN Breast Cancer Screening and Diagnosis Guidelines. The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM]. Version 1. Jenkintown, Pa: National Comprehensive Cancer Network; 2005.
81. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995;196:123-134.
82. Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2003;180:1225-1228.
83. Fornage BD, Toubas O, Morel M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer. 1987;60:765-771.
84. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221:641-649.
85. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WL. Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res. 1977;37:106-110.
86. Chow LW, Ho P. Hormonal receptor determination of 1052 Chinese breast cancers. J Surg Oncol. 2000;75:172-175.
87. Desai S, Ghosh TK, Chinoy R, Mohan A, Dinshaw KA. Telepathology at Tata Memorial Hospital, Mumbai and Barshi, a rural centre in Maharashtra. Natl Med J India. 2002;15:363-364.